A.R.T. Advisors’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-114,440
| Closed | -$1.09M | – | 1596 |
|
|
2019
Q1 | $1.09M | Buy |
+114,440
| New | +$1.09M | 0.07% | 448 |
|
|
2018
Q3 | – | Sell |
-46,406
| Closed | -$658K | – | 1674 |
|
|
2018
Q2 | $658K | Sell |
46,406
-108,000
| -70% | -$1.53M | 0.03% | 812 |
|
|
2018
Q1 | $2.93M | Buy |
154,406
+86,600
| +128% | +$1.65M | 0.12% | 246 |
|
|
2017
Q4 | $1.11M | Buy |
+67,806
| New | +$1.11M | 0.05% | 578 |
|
|
2017
Q3 | – | Sell |
-29,146
| Closed | -$256K | – | 1618 |
|
|
2017
Q2 | $256K | Buy |
+29,146
| New | +$256K | 0.01% | 1068 |
|
|
2017
Q1 | – | Sell |
-53,046
| Closed | -$161K | – | 1682 |
|
|
2016
Q4 | $161K | Buy |
+53,046
| New | +$161K | 0.01% | 1100 |
|
|
2016
Q2 | – | Sell |
-59,119
| Closed | -$357K | – | 1601 |
|
|
2016
Q1 | $357K | Buy |
59,119
+7,100
| +14% | +$42.9K | 0.02% | 984 |
|
|
2015
Q4 | $474K | Buy |
+52,019
| New | +$474K | 0.02% | 884 |
|
|
2015
Q3 | – | Sell |
-48,439
| Closed | -$537K | – | 1560 |
|
|
2015
Q2 | $537K | Sell |
48,439
-106,410
| -69% | -$1.18M | 0.02% | 967 |
|
|
2015
Q1 | $2.43M | Buy |
154,849
+131,110
| +552% | +$2.06M | 0.08% | 318 |
|
|
2014
Q4 | $361K | Buy |
23,739
+3,288
| +16% | +$50K | 0.01% | 1033 |
|
|
2014
Q3 | $220K | Sell |
20,451
-89,901
| -81% | -$967K | 0.01% | 1061 |
|
|
2014
Q2 | $1.69M | Buy |
110,352
+58,670
| +114% | +$896K | 0.09% | 330 |
|
|
2014
Q1 | $934K | Buy |
+51,682
| New | +$934K | 0.05% | 524 |
|
|
2013
Q4 | – | Sell |
-61,852
| Closed | -$648K | – | 1485 |
|
|
2013
Q3 | $648K | Buy |
61,852
+10,699
| +21% | +$112K | 0.04% | 664 |
|
|
2013
Q2 | $399K | Buy |
+51,153
| New | +$399K | 0.01% | 959 |
|